Thyme Care Secures $97M Series D to Expand AI-Driven Oncology Solutions
Thyme Care has raised $97 million in a Series D funding round, backed by strategic investors including CVS Health Ventures and JPMorgan Chase, to enhance its AI-driven oncology care solutions.